Skip to main content

Closed

TRAW: Traws Pharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Mixed

Revenue growth+1134.5% / yr

Operating margin0.0%

ROIC283.3%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio0.43×

Traws Pharma, Inc.

TRAWNASDAQ Global Market·USD·Closed

Traws Pharma, Inc.

TRAWNASDAQ·USD·Closed

$0.45

+2.02%

$0.45

+$0.01 (2.02%)

52W Range

1thpctl

Volume

0.04×avg

Mkt Cap

4.11MUSD

P/E

-0.5TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.04×avg

Market Cap

4.11MUSD

P/E Ratio

-0.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings